Robert Best, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1221 E Mcpherson Ave, Nashville, GA 31639 Phone: 229-433-8615 Fax: 229-433-8785 |
Integrative Practice Solutions Inc. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 201 W Marion Ave Ste A, Nashville, GA 31639 Phone: 229-322-4644 |
Mr. William Anthony Bush, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 405 Laurel St, Nashville, GA 31639 Phone: 229-543-7332 |
Logan Youngblood, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 405 Laurel St, Nashville, GA 31639 Phone: 229-543-7335 |
News Archive
Merck announced today that it is disappointed with the U.S. Supreme Court's decision to affirm a lower court's ruling on when the statute of limitations began to run in a federal securities class action against the company and certain of its officers and directors. The effect of the ruling is to return the case to federal district court in New Jersey for further proceedings.
Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that WuXi AppTec, a leading supplier of R&D services to the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, has purchased the Provantis Portal Remote Study Monitoring solution.
Acetaminophen (Tylenol and generics) is one of the most commonly used over-the-counter drugs in the United States. While generally safe, acetaminophen is known to cause severe liver injury if taken in high doses. But likely due to genetics, even the recommended dose can induce serious liver damage in a significant number of people.
Insulin is a key hormone in energy metabolism and blood sugar regulation. Normal insulin function in the body may be disturbed by e.g. overweight, leading to decreased insulin sensitivity and increased risk of developing type 2 diabetes and cardiovascular diseases.
Dr. Alon Friedman, a neurosurgeon, professor and researcher at Ben-Gurion University of the Negev, working with researchers from UC Berkeley, California have identified a TGF Beta Blocker that when given to rats prevents epilepsy after brain damage, according to a new study appearing in the July 15 issue of the Journal of Neuroscience.
› Verified 8 days ago